References
- Melamed ML, Eustace JA, Plantinga L, et al. (2006). Changes in serum calcium, phosphate, and PTH and the risk of death in incident dialysis patients: a longitudinal study. Kidney Int 70:351–7.
- Tentori F, Wang M, Bieber BA, et al. (2015). Recent changes in therapeutic approaches and association with outcomes among patients with secondary hyperparathyroidism on chronic hemodialysis: the DOPPS study. Clin J Am Soc Nephrol 10:98–109.
- Kong X, Zhang L, Zhang L, et al. (2012). Mineral and bone disorder in Chinese dialysis patients: a multicenter study. BMC Nephrol 13:116.
- National Kidney Foundation. (2003). K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42:S1–S201.
- Zhang JQ, Qiu M, Sheng JG, et al. (2013). Ultrasound-guided percutaneous thermal ablation for benign parathyroid nodules. Acad J Second Mil Med Univ 34:362–70 [in Chinese].
- Yu MA, Yao L, Zhang L, et al. (2015). Safety and efficiency of microwave ablation for recurrent and persistent secondary hyperparathyroidism after parathyroidectomy: a retrospective pilot study. Int J Hyperthermia 32:180–6.
- Diao Z, Liu X, Qian L, et al. (2016). Efficacy and its predictor in microwave ablation for severe secondary hyperparathyroidism in patients undergoing haemodialysis. Int J Hyperthermia 32:614–22.
- Puccini M, Carpi A, Cupisti A, et al. (2010). Total parathyroidectomy without autotransplantation for the treatment of secondary hyperparathyroidism associated with chronic kidney disease: clinical and laboratory long-term follow-up. Biomed Pharmacother 64:359–62.
- Shih ML, Duh QY, Hsieh CB, et al. (2009). Total parathyroidectomy without autotransplantation for secondary hyperparathyroidism. World J Surg 33:248–54.
- Jia X, Wang R, Zhang C, et al. (2015). Long-term outcomes of total parathyroidectomy with or without autoimplantation for hyperparathyroidism in chronic kidney disease: a meta-analysis. Ther Apher Dial 19:477–85.
- Lorenz K, Sekulla C, Dralle H. (2013). Surgical management of renal hyperparathyroidism. Zentralbl Chir 138:e47–54.
- Fukagawa M, Yokoyama K, Koiwa F, et al. (2013). Clinical practice guideline for the management of chronic kidney disease-mineral and bone disorder. Ther Apher Dial 17:247–88.
- KDIGO CKD-MBD Work Group. (2009). KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int Suppl S1–S130.
- Pacella CM, Mauri G, Achille G, et al. (2015). Outcomes and risk factors for complications of laser ablation for thyroid nodules: a multicenter study on 1531 patients. J Clin Endocrinol Metab 100:3903–10.
- Mauri G, Cova L, Monaco CG, et al. (2017). Benign thyroid nodules treatment using percutaneous laser ablation (PLA) and radiofrequency ablation (RFA). Int J Hyperthermia 33:295–9.
- Mauri G, Cova L, Ierace T, et al. (2016). Treatment of metastatic lymph nodes in the neck from papillary thyroid carcinoma with percutaneous laser ablation. Cardiovasc Intervent Radiol 39:1023–30.
- Mauri G, Cova L, Tondolo T, et al. (2013). Percutaneous laser ablation of metastatic lymph nodes in the neck from papillary thyroid carcinoma: preliminary results. J Clin Endocrinol Metab 98:E1203.
- Peng C, Zhang Z, Liu J, et al. (2017). Efficacy and safety of ultrasound-guided radiofrequency ablation of hyperplastic parathyroid gland for secondary hyperparathyroidism associated with chronic kidney disease. Head Neck 39:564–71.
- Sormaz IC, Poyanlı A, Açar S, et al. (2017). The results of ultrasonography-guided percutaneous radiofrequency ablation in hyperparathyroid patients in whom surgery is not feasible. Cardiovasc Intervent Radiol 40:596–602.
- Mauri G, Solbiati L. (2015). Virtual navigation and fusion imaging in percutaneous ablations in the neck. Ultrasound Med Biol 41:898.